Moreover, Western blot analyses of lysates derived from 6 distinct DLBCL models representing both ABC and GCB subtypes treated with voruciclib showed targeted downregulation of MCL-1 in comparison to the respective vehicle controls (Figs 2c, S2 and S5). Here, MCL1 is linked to diffuse large B-cell lymphoma.